US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Lunai Bioworks

2.16

-0.0450-2.05%

Pre-market: 2.280.1243+5.77%04:17 EDT

Volume:26.53K

Turnover:58.86K

Market Cap:9.77M

PE:-0.04

High:2.28

Open:2.25

Low:2.15

Close:2.20

52wk High:21.20

52wk Low:1.21

Shares:4.53M

Float Shares:2.92M

Volume Ratio:1.08

T/O Rate:0.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-61.5200

EPS(LYR):-86.2743

ROE:-325.46%

ROA:-9.65%

PB:-1.02

PE(LYR):-0.02

Loading ...

Overview Company News Filings

Lunai Bioworks Signs Collaboration Agreement with BrainStorm Therapeutics on Parkinson’s Disease Research

Lunai Bioworks - Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

THOMSON REUTERS

Lunai Bioworks (Nasdaq: Lnai) Signs Definitive Collaboration Agreement with Brainstorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027

THOMSON REUTERS

Lunai Bioworks Names 10 Defendants in Alleged Naked Short-Selling Fraud Lawsuit

Lunai Bioworks announces availability of CEO shareholder letter

Top Premarket Gainers

MT Newswires Live

Tianci International (CIIT) Stock Jumps Nearly 15% After Hours: Here's What Is Going On

Benzinga Earnings

Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing

THOMSON REUTERS

Lunai Bioworks regains Nasdaq $1 minimum bid price compliance, enters one-year monitoring period

Lunai Bioworks unit BioSymetrics enters neurology target discovery collaboration with BrainStorm Therapeutics

Lunai Bioworks and Brainstorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration

THOMSON REUTERS

Lunai Bioworks Inc - Federal Judge Grants Lunai Bioworks Expedited Discovery to Identify "Naked" Short Sellers

THOMSON REUTERS

Lunai Bioworks wins expedited discovery to identify alleged naked short sellers

Lunai Bioworks Inc. trading halted, news pending

Lunai Bioworks to Execute 1-for-8 Reverse Stock Split Effective May 22 to Regain Nasdaq Compliance

Lunai Bioworks announces reverse stock split

Lunai Bioworks effects 1-for-8 reverse stock split May 22

Lunai Bioworks, Inc. Announces Reverse Stock Split

THOMSON REUTERS

Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K

Benzinga Earnings

Lunai Bioworks Q3 FY26 net loss widens to $2.57 million; revenue $20,942

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/LNAI/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LNAI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","market":"US","secType":"STK","nameCN":"Lunai Bioworks","latestPrice":2.155,"timestamp":1787342400000,"preClose":2.2,"halted":0,"volume":26531,"hourTrading":{"tag":"盘前","latestPrice":2.2793,"preClose":2.155,"latestTime":"04:17 EDT","volume":1,"amount":2.2793,"timestamp":1787559455028,"change":0.1243,"changeRate":0.05768,"amplitude":0},"delay":0,"changeRate":-0.02045454545454562,"floatShares":2922000,"shares":4533900,"eps":-61.52,"marketStatus":"Pre-Mkt","change":-0.045,"latestTime":"08-24 05:49:16 EDT","open":2.25,"high":2.28,"low":2.15,"amount":58857.988791,"amplitude":0.059091,"askPrice":2.46,"askSize":100,"bidPrice":2.16,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-61.52,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":2.155,"preHourTrading":{"tag":"盘前","latestPrice":2.2793,"preClose":2.155,"latestTime":"04:17 EDT","volume":1,"amount":2.2793,"timestamp":1787559455028,"change":0.1243,"changeRate":0.05768,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":2.155,"preClose":2.155,"latestTime":"19:30 EDT","volume":65,"amount":141.0375,"timestamp":1787355005494,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0796809559094012,"impliedVol":1.4337,"impliedVolPercentile":0.8553},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LNAI\",,,,,undefined,":{"symbol":"LNAI","floatShares":2922000,"roa":"-9.65%","roe":"-325.46%","lyrEps":-86.274256,"volumeRatio":1.0796809559094012,"shares":4533900,"dividePrice":0,"high":2.28,"amplitude":0.059091,"preClose":2.2,"low":2.15,"week52Low":1.2104,"pbRate":"-1.02","psRate":"466.55","week52High":21.2,"institutionHeld":0,"latestPrice":2.155,"committee":0.904762,"eps":-61.52,"divideRate":0,"volume":26531,"delay":0,"ttmEps":-61.52,"open":2.25,"prevYearClose":7.0536,"prevWeekClose":2.155,"prevMonthClose":1.94,"prevQuarterClose":3.27,"fiveDayClose":2.22,"twentyDayClose":2.33,"sixtyDayClose":2.62},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LNAI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-05-22","symbol":"LNAI","defaultRemindTime":1779456600000,"type":"split","dateTimestamp":1779422400000,"forFactor":8,"toFactor":1,"ratio":8},{"market":"US","date":"2026-05-15","symbol":"LNAI","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"post","actualEps":-0.1},{"market":"US","date":"2026-02-17","symbol":"LNAI","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1771304400000,"reportTimeType":"","actualEps":null},{"market":"US","date":"2025-11-14","symbol":"LNAI","fiscalQuarterEnding":"2025/09","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763096400000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-09-30","symbol":"LNAI","defaultRemindTime":1759239000000,"type":"split","dateTimestamp":1759204800000,"forFactor":10,"toFactor":1,"ratio":10}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LNAI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LNAI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/LNAI\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"LNAI","date":"2026-08-21","current":-0.035029,"percent":0.841629,"low":-0.265446,"twenty":-0.163828,"median":-0.107366,"eighty":-0.079525,"high":-0.035532,"avg":-0.120419,"sd":0.047313,"marketCap":9974555},"quantilePoints":[{"date":"2025-10-03","current":-0.160171,"twenty":-0.164877,"median":-0.163112,"eighty":-0.161348,"marketCap":28511703},{"date":"2025-10-10","current":-0.161474,"twenty":-0.165919,"median":-0.164078,"eighty":-0.161474,"marketCap":28743506},{"date":"2025-10-17","current":-0.158869,"twenty":-0.16512,"median":-0.161474,"eighty":-0.158869,"marketCap":28279901},{"date":"2025-10-24","current":-0.135429,"twenty":-0.16512,"median":-0.160171,"eighty":-0.152098,"marketCap":24107456},{"date":"2025-10-31","current":-0.122514,"twenty":-0.163557,"median":-0.158218,"eighty":-0.135687,"marketCap":21808324},{"date":"2025-11-07","current":-0.132813,"twenty":-0.161474,"median":-0.152344,"eighty":-0.130739,"marketCap":23641716},{"date":"2025-11-14","current":-0.134115,"twenty":-0.161474,"median":-0.143888,"eighty":-0.121701,"marketCap":23873497},{"date":"2025-11-21","current":-0.254829,"twenty":-0.163557,"median":-0.147149,"eighty":-0.123011,"marketCap":33376540},{"date":"2025-11-28","current":-0.211108,"twenty":-0.166054,"median":-0.152344,"eighty":-0.125001,"marketCap":27650221},{"date":"2025-12-05","current":-0.232577,"twenty":-0.211108,"median":-0.158218,"eighty":-0.130221,"marketCap":30462108},{"date":"2025-12-12","current":-0.20753,"twenty":-0.221843,"median":-0.160171,"eighty":-0.132813,"marketCap":27181573},{"date":"2025-12-19","current":-0.184259,"twenty":-0.212897,"median":-0.161474,"eighty":-0.134115,"marketCap":24133572},{"date":"2025-12-26","current":-0.176388,"twenty":-0.211466,"median":-0.164729,"eighty":-0.134115,"marketCap":23102623},{"date":"2026-01-02","current":-0.157729,"twenty":-0.211108,"median":-0.164729,"eighty":-0.134896,"marketCap":20658806},{"date":"2026-01-09","current":-0.162828,"twenty":-0.208961,"median":-0.16538,"eighty":-0.135424,"marketCap":21326580},{"date":"2026-01-16","current":-0.16442,"twenty":-0.206179,"median":-0.165717,"eighty":-0.136203,"marketCap":21535113},{"date":"2026-01-23","current":-0.164223,"twenty":-0.200455,"median":-0.16538,"eighty":-0.13724,"marketCap":21509339},{"date":"2026-01-30","current":-0.150287,"twenty":-0.192502,"median":-0.16442,"eighty":-0.139063,"marketCap":19684091},{"date":"2026-02-06","current":-0.115725,"twenty":-0.190708,"median":-0.163453,"eighty":-0.135462,"marketCap":15157289},{"date":"2026-02-13","current":-0.146316,"twenty":-0.189626,"median":-0.161474,"eighty":-0.135462,"marketCap":19163931},{"date":"2026-02-20","current":-0.111222,"twenty":-0.189268,"median":-0.161474,"eighty":-0.134115,"marketCap":13960941},{"date":"2026-02-27","current":-0.077077,"twenty":-0.187121,"median":-0.158869,"eighty":-0.128849,"marketCap":9674942},{"date":"2026-03-06","current":-0.069658,"twenty":-0.184259,"median":-0.157729,"eighty":-0.122516,"marketCap":8743729},{"date":"2026-03-13","current":-0.037035,"twenty":-0.183139,"median":-0.156666,"eighty":-0.116398,"marketCap":4648809},{"date":"2026-03-20","current":-0.074186,"twenty":-0.178206,"median":-0.153221,"eighty":-0.113305,"marketCap":9312132},{"date":"2026-03-27","current":-0.095113,"twenty":-0.176388,"median":-0.150672,"eighty":-0.107552,"marketCap":11938878},{"date":"2026-04-02","current":-0.079389,"twenty":-0.176388,"median":-0.150189,"eighty":-0.092492,"marketCap":9965190},{"date":"2026-04-10","current":-0.079794,"twenty":-0.175994,"median":-0.147149,"eighty":-0.079794,"marketCap":10015984},{"date":"2026-04-17","current":-0.058578,"twenty":-0.173812,"median":-0.143919,"eighty":-0.0791,"marketCap":7352956},{"date":"2026-04-24","current":-0.088046,"twenty":-0.173794,"median":-0.139607,"eighty":-0.079389,"marketCap":11051809},{"date":"2026-05-01","current":-0.095356,"twenty":-0.173686,"median":-0.136115,"eighty":-0.079543,"marketCap":11969469},{"date":"2026-05-08","current":-0.096223,"twenty":-0.172094,"median":-0.135417,"eighty":-0.079543,"marketCap":12078282},{"date":"2026-05-15","current":-0.079926,"twenty":-0.171736,"median":-0.133464,"eighty":-0.079794,"marketCap":10032591},{"date":"2026-05-22","current":-0.082023,"twenty":-0.169948,"median":-0.130221,"eighty":-0.079389,"marketCap":10522249},{"date":"2026-05-29","current":-0.107441,"twenty":-0.168989,"median":-0.126835,"eighty":-0.079331,"marketCap":13783022},{"date":"2026-06-05","current":-0.1032,"twenty":-0.168377,"median":-0.122519,"eighty":-0.079512,"marketCap":13238955},{"date":"2026-06-12","current":-0.088356,"twenty":-0.168045,"median":-0.119258,"eighty":-0.079543,"marketCap":11334722},{"date":"2026-06-18","current":-0.14137,"twenty":-0.167069,"median":-0.118498,"eighty":-0.079694,"marketCap":18135556},{"date":"2026-06-26","current":-0.12582,"twenty":-0.166216,"median":-0.121361,"eighty":-0.079842,"marketCap":16140644},{"date":"2026-07-02","current":-0.109209,"twenty":-0.16583,"median":-0.118878,"eighty":-0.079874,"marketCap":14009717},{"date":"2026-07-10","current":-0.096485,"twenty":-0.165448,"median":-0.115725,"eighty":-0.079895,"marketCap":12377516},{"date":"2026-07-17","current":-0.101787,"twenty":-0.16538,"median":-0.113965,"eighty":-0.08033,"marketCap":13057600},{"date":"2026-07-24","current":-0.081995,"twenty":-0.165046,"median":-0.113282,"eighty":-0.081349,"marketCap":10518622},{"date":"2026-07-31","current":-0.071392,"twenty":-0.16452,"median":-0.112744,"eighty":-0.079874,"marketCap":9158455},{"date":"2026-08-07","current":-0.085529,"twenty":-0.164381,"median":-0.110215,"eighty":-0.079874,"marketCap":10972011},{"date":"2026-08-14","current":-0.079167,"twenty":-0.164194,"median":-0.108855,"eighty":-0.079874,"marketCap":10155911},{"date":"2026-08-21","current":-0.077754,"twenty":-0.163828,"median":-0.107366,"eighty":-0.079525,"marketCap":9974555}],"updateTime":1787537836471},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LNAI\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657756507","title":"Lunai Bioworks Signs Collaboration Agreement with BrainStorm Therapeutics on Parkinson’s Disease Research","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756507","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657756507?lang=en_us&edition=fundamental","pubTime":"2026-08-05 03:29","pubTimestamp":1785871775,"startTime":"0","endTime":"0","summary":"Lunai Bioworks signs collaboration agreement with BrainStorm Therapeutics on Parkinson’s disease researchLunai Bioworks signed a Master Collaboration Agreement with BrainStorm Therapeutics focused on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL76pPQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565078","title":"Lunai Bioworks - Initial Parkinson's Disease Data Readout Targeted for First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565078","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657565078?lang=en_us&edition=fundamental","pubTime":"2026-08-05 03:29","pubTimestamp":1785871755,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA9QTWP9:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657073565","title":"Lunai Bioworks (Nasdaq: Lnai) Signs Definitive Collaboration Agreement with Brainstorm Therapeutics; Initial Parkinson's Disease Data Readout Targeted for First Half of 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2657073565","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657073565?lang=en_us&edition=fundamental","pubTime":"2026-08-05 03:29","pubTimestamp":1785871755,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nTUA9QTWP9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656355189","title":"Lunai Bioworks Names 10 Defendants in Alleged Naked Short-Selling Fraud Lawsuit","url":"https://stock-news.laohu8.com/highlight/detail?id=2656355189","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656355189?lang=en_us&edition=fundamental","pubTime":"2026-08-04 21:20","pubTimestamp":1785849624,"startTime":"0","endTime":"0","summary":"Lunai Bioworks names 10 defendants in alleged naked short-selling fraud lawsuitLunai Bioworks filed a first amended complaint in Delaware federal court naming 10 defendants over an alleged coordinated","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL9JB8Lq:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644749489","title":"Lunai Bioworks announces availability of CEO shareholder letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2644749489","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644749489?lang=en_us&edition=fundamental","pubTime":"2026-06-17 21:15","pubTimestamp":1781702132,"startTime":"0","endTime":"0","summary":"Lunai Bioworks announced the availability of a CEO letter to shareholders outlining strategy across AI-enabled biodefense, precision neurology, litigation.Letter cites an April multi-year defense collaboration via BioSymetrics to deploy an AI platform for chemical threat assessment as first revenue contract.Highlights formation of the Pathfinder Consortium with major universities, positioning the Augusta platform for broader defense demand in 2H 2026.Notes neurology work in epilepsy, Parkinson’s, Alzheimer’s; references a Phase I/II STTR grant of USD 1.85 million for alcohol use disorder research.Discloses May Delaware lawsuit alleging naked short selling; cites 29,600,000 failing-to-deliver shares, 554,000,000 shares traded on March 17.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260617:nNDL2CKsFF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644487717","title":"Top Premarket Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2644487717","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644487717?lang=en_us&edition=fundamental","pubTime":"2026-06-17 19:08","pubTimestamp":1781694484,"startTime":"0","endTime":"0","summary":"Eshallgo  shares were up 296% in Wednesday premarket activity, adding to gains from the previous session.Azitra  shares were up 93% after the company said it will present updates on its pipeline, including a protein and peptide program for the cosmetic and cosmeceutical markets, at an upcoming conference.J-Star  stock was up 86% after a 37% decline in the previous session.Lunai Bioworks  stock was up 79%, continuing from Tuesday's 9% gain.Tianci International  shares were up 43%, recovering from the previous session's 70% decline","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["YMAT","LNAI","EHGO","BK4021","BK4139","CIIT","AZTR","BK4190","BK4143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644715592","title":"Tianci International (CIIT) Stock Jumps Nearly 15% After Hours: Here's What Is Going On","url":"https://stock-news.laohu8.com/highlight/detail?id=2644715592","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644715592?lang=en_us&edition=fundamental","pubTime":"2026-06-17 14:57","pubTimestamp":1781679444,"startTime":"0","endTime":"0","summary":"Tianci International Inc. shares jumped 14.91% after-hours following a discounted share offering and delayed quarterly filing update.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/markets/equities/26/06/53242009/tianci-international-ciit-stock-jumps-nearly-15-after-hours-heres-what-is-going-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4150","LNAI","BK4139","BK4021","CIIT","RSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644767465","title":"Lunai Bioworks - Regains Nasdaq Compliance With Minimum $1 Bid Price Rule - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2644767465","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644767465?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:02","pubTimestamp":1781640141,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nFWN42O0P1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644176745","title":"Lunai Bioworks regains Nasdaq $1 minimum bid price compliance, enters one-year monitoring period","url":"https://stock-news.laohu8.com/highlight/detail?id=2644176745","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2644176745?lang=en_us&edition=fundamental","pubTime":"2026-06-17 04:01","pubTimestamp":1781640101,"startTime":"0","endTime":"0","summary":"Lunai Bioworks regained compliance with Nasdaq’s $1 minimum bid price rule, clearing a key listing risk flagged in prior panel extensions.Nasdaq imposed a mandatory one-year panel monitor starting June 11, 2026.A fresh bid-price breach during monitoring would trigger an immediate delisting determination, with no compliance plan or added cure period available.The company would still be able to request a new Nasdaq Hearings Panel hearing, which would stay any suspension or delisting pending the outcome.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities an","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260616:nNDLbpcr4D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638696607","title":"Lunai Bioworks unit BioSymetrics enters neurology target discovery collaboration with BrainStorm Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2638696607","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638696607?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:15","pubTimestamp":1779974129,"startTime":"0","endTime":"0","summary":"Lunai Bioworks’ wholly owned subsidiary BioSymetrics signed a strategic collaboration LOI with BrainStorm Therapeutics to discover neurology drug targets.LouLou Foundation grant backs initial work in rare genetic epilepsies; broader scope includes Parkinson’s disease programs.BioSymetrics will pair its AI target discovery with zebrafish in vivo validation, integrated with BrainStorm’s human-derived brain organoid systems.Parkinson’s effort combines BrainStorm’s midbrain organoid foundation model with BioSymetrics’ analysis of the PPMI dataset to identify progression biomarkers.Companies aim to generate validated, partnerable neurology assets for licensing or downstream development.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nNDL7Rwc79:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638069669","title":"Lunai Bioworks and Brainstorm Therapeutics Launch Foundation-Funded Parkinson's and Rare Epilepsy AI Discovery Collaboration","url":"https://stock-news.laohu8.com/highlight/detail?id=2638069669","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638069669?lang=en_us&edition=fundamental","pubTime":"2026-05-28 21:15","pubTimestamp":1779974101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260528:nTUAYMJQX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637129843","title":"Lunai Bioworks Inc - Federal Judge Grants Lunai Bioworks Expedited Discovery to Identify \"Naked\" Short Sellers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637129843","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637129843?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:16","pubTimestamp":1779455817,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nFWN41Z105:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637312607","title":"Lunai Bioworks wins expedited discovery to identify alleged naked short sellers","url":"https://stock-news.laohu8.com/highlight/detail?id=2637312607","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637312607?lang=en_us&edition=fundamental","pubTime":"2026-05-22 21:15","pubTimestamp":1779455735,"startTime":"0","endTime":"0","summary":"Lunai Bioworks won a court order in Delaware allowing expedited third-party discovery to identify unnamed defendants it alleges engaged in “naked” short selling of its Nasdaq-listed common stock in late 2025 and the first half of 2026.The magistrate judge found good cause for early discovery, citing a prima facie showing on at least some claims and the need to obtain identifying information held by broker-dealers, custodians, market infrastructure entities, or market participants.The lawsuit, filed May 11, 2026, alleges securities fraud under Section 10 and Rule 10b-5, market manipulation under Section 9, and wire fraud as an intentional tort, seeking damages and injunctive relief.The case targets “John Doe” defendants pending identification through discovery, with the company signaling it may later add civil RICO claims that could increase potential damages.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260522:nNDLbqPLSn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637363609","title":"Lunai Bioworks Inc. trading halted, news pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2637363609","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2637363609?lang=en_us&edition=fundamental","pubTime":"2026-05-22 07:50","pubTimestamp":1779407436,"startTime":"0","endTime":"0","summary":"19:50 EDT Lunai Bioworks (LNAI) Inc. trading halted, news pending Published first on TheFly – the ultimate source for real-time, market-moving brea...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-inc-trading-halted-news-pending-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195656015","title":"Lunai Bioworks to Execute 1-for-8 Reverse Stock Split Effective May 22 to Regain Nasdaq Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1195656015","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195656015?lang=en_us&edition=fundamental","pubTime":"2026-05-21 03:11","pubTimestamp":1779304289,"startTime":"0","endTime":"0","summary":"The AI-driven life sciences company Lunai Bioworks announced on Wednesday a 1-for-8 reverse split of its common stock. The consolidation will become effective at 12:01 a.m. Eastern Time on May 22,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQE","07261","BK1147","BK4007","JEPQ","QQQA","07522","09086","03455","QMAR","02834","NAPR","MNQmain","GPIQ","QLD","QQQJ","NJAN","QQQ","07266","NVIW.SI","QDEC","QQQY","SQQQ","QQQM","QID","ONEQ","PSQ","09834","NJUL","03034","TQQQ","BK4139","QQQX","QYLG","07568","QDTE","TQQY","FTEC","LNAI","NOCT","IYW","TECS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636455840","title":"Lunai Bioworks announces reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636455840","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636455840?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:21","pubTimestamp":1779283265,"startTime":"0","endTime":"0","summary":"Lunai Bioworks (LNAI) announced that it will effect a reverse stock split of its issued and outstanding common stock, par value $0.0001 per share, ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-announces-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/lunai-bioworks-announces-reverse-stock-split-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636642840","title":"Lunai Bioworks effects 1-for-8 reverse stock split May 22","url":"https://stock-news.laohu8.com/highlight/detail?id=2636642840","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636642840?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:15","pubTimestamp":1779282922,"startTime":"0","endTime":"0","summary":"Lunai Bioworks will carry out a 1-for-8 reverse stock split effective 12:01 a.m. ET on May 22, 2026.Shares are set to trade on a split-adjusted basis on Nasdaq at the open on May 22 under the LNAI ticker.The move targets a higher share price to help regain compliance with Nasdaq’s $1 minimum bid requirement.Issued shares are expected to drop to about 4,533,890 from about 36,271,119, subject to rounding for fractional shares.A new CUSIP, 29350E302, will take effect following the split.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nNDLc76XMp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","LNAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636840663","title":"Lunai Bioworks, Inc. Announces Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2636840663","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2636840663?lang=en_us&edition=fundamental","pubTime":"2026-05-20 21:15","pubTimestamp":1779282902,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260520:nTUA4H1RSQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635055865","title":"Lunai Bioworks Inc. - Common Stock Q3 EPS $(0.10), Sales $20.942K","url":"https://stock-news.laohu8.com/highlight/detail?id=2635055865","media":"Benzinga Earnings","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635055865?lang=en_us&edition=fundamental","pubTime":"2026-05-16 06:19","pubTimestamp":1778883561,"startTime":"0","endTime":"0","summary":"Lunai Bioworks Inc. - Common Stock (NASDAQ:LNAI) reported quarterly losses of $(0.10) per share.  The company reported $20.942 thousand in sales this quarter.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52620268/lunai-bioworks-inc-common-stock-q3-eps-0-10-sales-20-942k","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["QQQ","BK4139","NDX","QQQJ","IYW","GPIQ","MNQmain",".IXIC","QQQE","PSQ","QLD","QID","NQmain","FTEC","QDTE","QQQY","TQQY","JEPQ","NVIW.SI","ONEQ","LNAI","QQQM","QYLG","TECS","SQQQ","TQQQ","QQQA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635058308","title":"Lunai Bioworks Q3 FY26 net loss widens to $2.57 million; revenue $20,942","url":"https://stock-news.laohu8.com/highlight/detail?id=2635058308","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635058308?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:50","pubTimestamp":1778878241,"startTime":"0","endTime":"0","summary":"Lunai Bioworks posted a net loss of USD 2.57 million for quarter ended March 31, 2026, swinging from net income of USD 189,176 a year earlier as operating loss narrowed 66% to USD 1.43 million.Revenue was USD 20,942, compared with no revenue a year earlier, while operating expenses fell 65% to USD 1.45 million on a 66% drop in general and administrative costs to USD 1.42 million.Cash and cash equivalents totaled USD 3.16 million at March 31, 2026, up from USD 92,700 at June 30, 2025, while working capital deficit narrowed 45% to USD 15.55 million.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lunai Bioworks Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retr","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9VSRR7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":"Lunai Bioworks Q3 FY26 net loss widens to $2.57 million; revenue $20,942","news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LNAI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}